S. Kuriyama

发表

Loss of p57KIP2 is associated with colorectal carcinogenesis.

Jia-qing Li, Fei Wu, H. Usuki, 2003, International journal of oncology.

Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.

H. Yoshiji, T. Masaki, S. Kuriyama, 2006, International journal of molecular medicine.

Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.

T. Masaki, S. Kuriyama, K. Kurokohchi, 2004, International journal of oncology.

Cyclins and cyclin‐dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis

Yoshiaki Miyauchi, Tsutomu Masaki, Kouichi Igarashi, 2003, Hepatology.

Analysis of intrahepatic invasion of hepatocellular carcinoma using fluorescent dye-labeled cells in mice.

H. Yoshiji, S. Kuriyama, S. Nagao, 1998, Anticancer research.

Percutaneous ethanol and lipiodol injection therapy for hepatocellular carcinoma.

T. Masaki, S. Kuriyama, A. Morishita, 2004, International journal of oncology.

Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.

T. Masaki, S. Kuriyama, K. Kurokohchi, 2002, International journal of oncology.

Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.

H. Yoshiji, S. Kuriyama, Q. Chen, 2001, European journal of cancer.

Hepatocellular carcinoma in an orthotopic mouse model metastasizes intrahepatically in cirrhotic but not in normal liver

H. Yoshiji, S. Kuriyama, T. Tsujimoto, 1999, International journal of cancer.

Successful laparoscopic radiofrequency ablation of hepatocellular carcinoma adhered to the mesentery after transcatheter arterial embolization.

T. Masaki, S. Kuriyama, Hirohito Yoneyama, 2005, Oncology reports.

Technique for measuring the rotational velocity of a single cell

K. Takegawa, S. Kuriyama, I. Ishimaru, 2007 .

Variable phase-contrast fluorescence spectrometry for fluorescently stained cells

K. Takegawa, S. Kuriyama, S. Nakai, 2006 .

A double filtering method for measuring the translational velocity of fluorescently stained cells

K. Takegawa, S. Kuriyama, I. Ishimaru, 2007 .

Method for measuring the three-dimensional distribution of a fluorescent dye in a cell membrane

K. Takegawa, S. Kuriyama, I. Ishimaru, 2007 .

Translational velocity measurement for single floating cell based on optical Fourier transform theory

K. Takegawa, S. Kuriyama, S. Nakai, 2006 .

Attitudinal manipulation of an optically trapped bacillary probe by controlling the distance between focal points for local dosing in cells

K. Takegawa, S. Kuriyama, S. Nakai, 2006 .

Three-dimensional phase-contrast imaging of single floating cells

K. Takegawa, S. Kuriyama, S. Nakai, 2006 .

Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.

H. Yoshiji, S. Kuriyama, T. Tsujimoto, 2006, International journal of molecular medicine.

Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats.

H. Yoshiji, S. Kuriyama, M. Yamazaki, 2005, Anticancer research.

Cyclin B1, unlike cyclin G1, increases significantly during colorectal carcinogenesis and during later metastasis to lymph nodes.

H. Maeta, Jia-qing Li, Fei Wu, 2003, International journal of oncology.

Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy.

H. Yoshiji, S. Kuriyama, H. Fukui, 2004, Current cancer drug targets.

Activation of c-Yes in hepatocellular carcinoma: a preliminary study.

H. Yoshiji, H. Usuki, T. Masaki, 2006, World journal of gastroenterology.

Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy

S. Kuriyama, Z. Qi, S. Nagao, 1999, Cancer Gene Therapy.

Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter

S. Kuriyama, Z. Qi, M. Kikukawa, 1999, Gene Therapy.

Comparison of carcinoembryonic antigen promoter regions isolated from human colorectal carcinoma and normal adjacent mucosa to induce strong tumor‐selective gene expression

S. Kuriyama, Z. Qi, A. Mitoro, 1998, International journal of cancer.

Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients.

H. Usuki, S. Kuriyama, A. Deguchi, 2008, Biochemical and biophysical research communications.

A Potential Serum N-glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis

T. Masaki, S. Kuriyama, A. Deguchi, 2020, International journal of molecular sciences.

Immune response to suicide gene therapy.

H. Yoshiji, S. Kuriyama, H. Tsujinoue, 2004, Methods in molecular medicine.

Hydroxyapatite ceramics as a carrier of gene-transduced bone marrow cells

H. Ohgushi, S. Kuriyama, Y. Takakura, 2002, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

Enhanced expression of p46 Shc in the nucleus and p52 Shc in the cytoplasm of human gastric cancer.

H. Yoshiji, H. Usuki, T. Masaki, 2005, International journal of oncology.

Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.

H. Yoshiji, T. Masaki, S. Kuriyama, 2004, International journal of oncology.

Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.

S. Kuriyama, A. Mitoro, M. Yamazaki, 1999, Scandinavian journal of gastroenterology.

Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development.

H. Yoshiji, S. Kuriyama, T. Tsujimoto, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Combination of interferon‐β and angiotensin‐converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development

H. Yoshiji, S. Kuriyama, M. Yamazaki, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Abundance of microRNA target motifs in the 3′‐UTRs of 20 527 human genes

T. Masaki, S. Kuriyama, H. Iwama, 2007, FEBS letters.

CLINICAL SIGNIFICANCE OF ENDOSCOPIC METHYLENE BLUE STAINING FOR INTESTINAL METAPLASIA IN BARRETT'S EPITHELIUM

S. Kuriyama, M. Nishioka, Toshiyuki Kagawa, 2001 .

Expression of p57KIP2 in hepatocellular carcinoma: relationship between tumor differentiation and patient survival

T. Masaki, S. Kuriyama, Y. Shiratori, 2002 .

Clinical Characteristics of Patients with Hepatitis C Virus-Related Chronic Liver Disease Seropositive for Anticentromere Antibody

R. Haba, T. Masaki, S. Kuriyama, 2009, Digestive Diseases and Sciences.

Usefulness of liver infiltrating CD86-positive mononuclear cells for diagnosis of autoimmune hepatitis.

T. Masaki, S. Kuriyama, A. Morishita, 2006, World journal of gastroenterology.

Analysis of CD28 and bcl-2 Expression on Peripheral Blood and Liver-Infiltrating Mononuclear Cells in Patients with Autoimmune Hepatitis

T. Masaki, S. Kuriyama, A. Morishita, 2006, Journal of Clinical Immunology.

Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C.

T. Masaki, S. Kuriyama, Hirohito Yoneyama, 2010, Experimental and therapeutic medicine.

Aberrant cytokeratin expression and high susceptibility to apoptosis in autoimmune hepatitis.

Fei Wu, T. Masaki, J. Fujita, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Reduced expression of cell cycle regulator p18INK4C in human hepatocellular carcinoma

H. Yoshiji, H. Usuki, T. Masaki, 2004, Hepatology.

GnT V-Catalyzed N-glycan Products are not increased in Hepatomas

T. Masaki, S. Kuriyama, A. Deguchi, 2013 .

Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis.

S. Kuriyama, T. Tsujimoto, H. Fukui, 2001, Liver.

Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis

S. Kuriyama, R. Coppel, M. Nishioka, 2005, Hepatology.

Rapid onset of glycogen storage hepatomegaly in a type-2 diabetic patient after a massive dose of long-acting insulin and large doses of glucose.

H. Yoshiji, S. Kuriyama, T. Tsujimoto, 2006, Internal medicine.

Particle-mediated gene transfer into murine livers using a newly developed gene gun

H. Yoshiji, S. Kuriyama, A. Mitoro, 2000, Gene Therapy.

In vivo depletion of macrophages by desulfated ι-carrageenan in mice

S. Kuriyama, S. Ishizaka, T. Tsuji, 1989 .

Coexistence of Splenic Non-Hodgkin's Lymphoma With Hepatocellular Carcinoma in a Patient With Chronic Hepatitis C

R. Haba, T. Masaki, S. Kuriyama, 2006, Digestive Diseases and Sciences.

Construction of retroviral vectors to induce strong hepatoma cell‐specific expression of cytokine genes

S. Kuriyama, Z. Qi, G. Cao, 1996, Journal of gastroenterology and hepatology.

Tissue‐specific expression of HSV‐tk gene can induce efficient antitumor effect and protective immunity to wild‐type hepatocellular carcinoma

S. Kuriyama, K. Ikenaka, M. Kikukawa, 1997, International journal of cancer.

Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, International journal of oncology.

Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.

H. Yoshiji, T. Masaki, S. Kuriyama, 2007, International journal of oncology.

Enlargement of thermal ablation zone by the combination of ethanol injection and radiofrequency ablation in excised bovine liver.

T. Masaki, S. Kuriyama, T. Himoto, 2004, International journal of oncology.

The vascular endothelial growth factor receptor KDR/Flk‐1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model

H. Yoshiji, D. Hicklin, S. Kuriyama, 2001, Hepatology.

Anti‐cytokeratin antibodies in sera of the patients with autoimmune hepatitis

J. Fujita, S. Kuriyama, Y. Ohtsuki, 2001, Clinical and experimental immunology.

Endothelin-1 plays a major role in portal hypertension of biliary cirrhotic rats through endothelin receptor subtype B together with subtype A in vivo.

H. Yoshiji, S. Kuriyama, H. Imazu, 2001, Journal of hepatology.

A potential approach for electrochemotherapy against colorectal carcinoma using a clinically available alternating current system with bipolar snare in a mouse model.

H. Yoshiji, S. Kuriyama, A. Mitoro, 2001, Scandinavian journal of gastroenterology.

Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies

H. Yoshiji, Y. Kita, S. Kuriyama, 2004, Gut.

Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver

H. Yoshiji, S. Kuriyama, S. Nagao, 1999, Gene Therapy.

Effects of glycyrrhizin on immune‐mediated cytotoxicity

S. Kuriyama, H. Kawamoto, N. Hozumi, 1997, Journal of gastroenterology and hepatology.

Usefulness of single and repetitive percutaneous transhepatic gallbladder aspiration for the treatment of acute cholecystitis

T. Masaki, S. Kuriyama, N. Uchida, 2007, Journal of Gastroenterology.

[Gastroesophageal reflux disease in diabetic patients].

S. Kuriyama, Hideyuki Inoue, F. Kinekawa, 2004, Nihon rinsho. Japanese journal of clinical medicine.

CD28–Negative CD8–Positive Cytotoxic T Lymphocytes Mediate Hepatocellular Damage in Hepatitis C Virus Infection

T. Masaki, S. Kuriyama, Hirohito Yoneyama, 2003, Journal of Clinical Immunology.

Effects of ursodeoxycholic acid on target apoptosis induced by an antigen-specific CD4+-T cell line

S. Kuriyama, N. Hozumi, H. Fukui, 1996 .

Effects of ursodeoxycholic acid on antigen presentation

S. Kuriyama, Y. Matsumura, N. Hozumi, 1993 .

Autoreactive helper T cells specific for cytokeratin 19 in patients with autoimmune hepatitis.

Fei Wu, T. Masaki, J. Fujita, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Retrovirus-mediated in vivo gene therapy using the herpes simplex virus thymidine kinase gene against carcinomatous peritonitis.

H. Yoshiji, S. Kuriyama, A. Mitoro, 2000, Scandinavian journal of gastroenterology.

Atrial fibrillation induced by simvastatin treatment in a 61-year-old man

S. Kuriyama, K. Mizushige, H. Fukui, 2003, Heart and Vessels.

The copper‐chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells

D. Gomez, H. Yoshiji, S. Kuriyama, 2001, International journal of cancer.

Pancreatic pleural effusion with a pancreaticopleural fistula diagnosed by magnetic resonance cholangiopancreatography and cured by somatostatin analogue treatment

H. Yoshiji, S. Kuriyama, M. Kikukawa, 2003, Abdominal Imaging.

The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study

S. Kaneko, S. Kuriyama, S. Onishi, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Cytosine deaminase/5‐fluorocytosine gene therapy can induce efficient anti‐tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice

H. Yoshiji, S. Kuriyama, K. Ikenaka, 1999, International journal of cancer.

Bacterial cytosine deaminase suicide gene transduction renders hepatocellular carcinoma sensitive to the prodrug 5-fluorocytosine

S. Kuriyama, K. Ikenaka, C. Mullen, 1995 .

Improvement of retroviral packaging cell lines by introducing the polyomavirus early region.

S. Kuriyama, K. Ikenaka, T. Yoshimatsu, 1998, Human gene therapy.

Assessment of efficiency and safety of adenovirus mediated gene transfer into normal and damaged murine livers

H. Yoshiji, S. Kuriyama, S. Nagao, 2000, Gut.

Effects of continuous intrahepatic administration of transforming growth factor-beta on immunoglobulin production

S. Kuriyama, T. Nakatani, H. Fukui, 1995 .

A novel oral adjuvant for hepatitis B virus (HBV) vaccines.

S. Kuriyama, S. Ishizaka, T. Tsujii, 1990, Journal of hepatology.

A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retroviral vector.

K. Mikoshiba, S. Kuriyama, N. Morita, 1991, Cell structure and function.

Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-alpha.

T. Masaki, S. Kuriyama, K. Kurokohchi, 2005, World journal of gastroenterology.

Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene

H. Yoshiji, S. Kuriyama, S. Nagao, 1999, Gene Therapy.

Estimation of the stent placement above the intact sphincter of Oddi against malignant bile duct obstruction

T. Masaki, S. Kuriyama, Seishiro Watanabe, 2005, Journal of Gastroenterology.

Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment

S. Kuriyama, K. Ikenaka, M. Kikukawa, 1998, Gene Therapy.

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats.

H. Yoshiji, S. Kuriyama, T. Tsujimoto, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Is the questionnaire for the assessment of gastroesophageal reflux useful for diabetic patients?

S. Kuriyama, Hideyuki Inoue, F. Kinekawa, 2005, Scandinavian journal of gastroenterology.

A novel approach for inducing enhanced and selective transgene expression in hepatocellular‐carcinoma cells

S. Kuriyama, A. Mitoro, H. Tsujinoue, 2000, International journal of cancer.

Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.

H. Yoshiji, T. Masaki, S. Kuriyama, 2007, International journal of molecular medicine.

Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma

H. Yoshiji, D. Hicklin, S. Kuriyama, 2002, Hepatology.

Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease

T. Masaki, S. Kuriyama, T. Himoto, 2007, Scandinavian journal of gastroenterology.

Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, Oncology reports.

Evaluation of prodrugs ability to induce effective ablation of cells transduced with viral thymidine kinase gene.

S. Kuriyama, K. Ikenaka, T. Nakatani, 1996, Anticancer research.

Further resolution of α‐fetoprotein glycoforms by two‐dimensional isoelectric focusing and lectin affinity electrophoresis

T. Masaki, S. Kuriyama, N. Uchida, 2006, Electrophoresis.

Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma

S. Kuriyama, K. Ikenaka, T. Nakatani, 1995, Hepatology.

Selective expression of foreign genes in glioma cells: Use of the mouse myelin basic protein gene promoter to direct toxic gene expression

K. Mikoshiba, S. Kuriyama, M. Yamada, 1993, Journal of neuroscience research.

Adenocarcinoma arising from aberrant pancreas in the stomach

S. Kuriyama, N. Uchida, T. Ando, 2005, Journal of Gastroenterology.

The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.

H. Yoshiji, S. Kuriyama, H. Tsujinoue, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Fulminant hepatic failure caused by malignant melanoma of unknown primary origin

T. Masaki, S. Kuriyama, K. Kurokohchi, 2004, Journal of Gastroenterology.

A simplified general method for determination of recombinant retrovirus titers.

S. Kuriyama, T. Hayakawa, K. Ikenaka, 1995, Cell structure and function.

Gene therapy for the treatment of hepatoma by retroviral-mediated gene transfer of the herpes simplex virus thymidine kinase

S. Kuriyama, K. Ikenaka, T. Nakatani, 1993 .

Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene

K. Mikoshiba, H. Okano, Y. Inoue, 1994, Neuron.

Concomitant colitis associated with primary sclerosing cholangitis

T. Masaki, S. Kuriyama, Seishiro Watanabe, 2003, Journal of Gastroenterology.

Combination of assay of human telomerase reverse transcriptase mRNA and cytology using bile obtained by endoscopic transpapillary catheterization into the gallbladder for diagnosis of gallbladder carcinoma.

T. Masaki, S. Kuriyama, Seishiro Watanabe, 2003 .

T. Masaki, S. Kuriyama, Seishiro Watanabe, 2003, American Journal of Gastroenterology.

Reply:

T. Masaki, S. Kuriyama, A. Morishita, 2005 .

ENDOSCOPIC TRANSPAPILLARY CATHETERIZATION INTO THE GALLBLADDER FOR DIAGNOSIS OF GALLBLADDER CARCINOMA

S. Kuriyama, N. Uchida, H. Kamada, 2006 .

Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer.

S. Kuriyama, Z. Qi, G. Cao, 1997, Gastroenterology.

p107 Expression in colorectal tumours rises during carcinogenesis and falls during invasion.

J. Fujita, S. Kuriyama, K. Imaida, 2002, European journal of cancer.

Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.

H. Yoshiji, H. Usuki, S. Kuriyama, 2005, International journal of oncology.

Ultrasonographic findings of amebic colitis

H. Yoshiji, S. Kuriyama, T. Tsujimoto, 2003, Journal of Gastroenterology.

Perindopril: possible use in cancer therapy

H. Yoshiji, S. Kuriyama, H. Fukui, 2002, Anti-cancer drugs.

KDR/Flk‐1 is a major regulator of vascular endothelial growth factor–induced tumor development and angiogenesis in murine hepatocellular carcinoma cells

H. Yoshiji, D. Hicklin, S. Kuriyama, 1999, Hepatology.

Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.

Tsutomu Masaki, H. Yoshiji, T. Masaki, 2005, American journal of physiology. Gastrointestinal and liver physiology.

Mediastinal pancreatic pseudocyst caused by obstruction of the pancreatic duct was eliminated by bromhexine hydrochloride.

S. Kuriyama, T. Tsujimoto, Y. Matsumura, 2004, Internal medicine.

[A case of mediastinal pancreatic pseudocyst with pleural effusion caused obstruction of pancreatic duct by protein plug].

H. Yoshiji, S. Kuriyama, T. Tsujimoto, 2002, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Tissue inhibitor of metalloproteinases‐1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse

H. Yoshiji, S. Kuriyama, H. Imazu, 2002, Hepatology.

Tissue inhibitor of metalloproteinases‐1 promotes liver fibrosis development in a transgenic mouse model

S. Thorgeirsson, D. Gomez, H. Yoshiji, 2000, Hepatology.

Measurement of left portal vein blood-flow velocity by Doppler sonography in a patient with acute fatty liver of pregnancy

T. Masaki, S. Kuriyama, K. Kurokohchi, 2003, Journal of Medical Ultrasonics.

Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells

H. Yoshiji, S. Kuriyama, M. Yamazaki, 1998, Hepatology.

INTERNAL DRAINAGE OF AN ENDOSCOPIC NASOPANCREATOBILIARY DRAINAGE TUBE USING ENDOSCOPICALLY AVAILABLE SCISSOR FORCEPS

T. Masaki, S. Kuriyama, Hideyuki Inoue, 2004 .

Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis.

H. Yoshiji, M. Shibuya, S. Kuriyama, 1999, Cancer research.

Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.

Jia-qing Li, Fei Wu, A. Kubo, 2004, International journal of oncology.

Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development.

H. Yoshiji, S. Kuriyama, H. Imazu, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.

H. Yoshiji, S. Kuriyama, H. Imazu, 2002, Journal of hepatology.

Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

H. Yoshiji, S. Kuriyama, H. Tsujinoue, 2001, Hepatology.

Spontaneous elimination of serum HCV-RNA after total gastrectomy for early gastric cancer in a patient with chronic hepatitis C.

H. Yoshiji, S. Kuriyama, H. Fukui, 2001 .

Spontaneous elimination of serum HCV-RNA after total gastrectomy for early gastric cancer in a patient with chronic hepatitis C

H. Yoshiji, S. Kuriyama, H. Fukui, 2001, American Journal of Gastroenterology.

Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan

H. Yoshiji, S. Kuriyama, M. Shima, 1995, Journal of Gastroenterology.

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

H. Yoshiji, D. Hicklin, T. Masaki, 2003, Gut.

Tissue inhibitor of metalloproteinases‐1 (TIMP‐1) inhibits tumor growth and angiogenesis in the TIMP‐1 transgenic mouse model

H. Yoshiji, T. Masaki, S. Kuriyama, 2003, International journal of cancer.

In vivo depletion of macrophages by desulfated iota-carrageenan in mice.

S. Kuriyama, S. Ishizaka, T. Tsujii, 1989, Journal of immunological methods.

Transfer of new dwarfing genes from the weed species Avena fatua into cultivated oat A. byzantina

S. Kuriyama, T. Morikawa, M. Sumiya, 2007 .

How many cytological examinations should be performed for the diagnosis of malignant biliary stricture via an endoscopic nasobiliary drainage tube?

T. Masaki, S. Kuriyama, N. Uchida, 2008, Journal of gastroenterology and hepatology.

A case of early gastric malignant lymphoma diagnosed and completely resected by strip biopsy

H. Yoshiji, S. Kuriyama, Y. Konishi, 1995, Journal of Gastroenterology.

Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.

H. Yoshiji, S. Kuriyama, K. Asada, 2006, Oncology reports.

Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, Journal of hepatology.

Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.

H. Yoshiji, S. Kuriyama, K. Ikenaka, 1998, Anticancer research.

Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.

T. Masaki, S. Kuriyama, Jian-ying Zhang, 2005, International journal of oncology.

Abnormal bile flow in patients with achalasia

S. Kuriyama, K. Kurokohchi, N. Uchida, 2003, Journal of Gastroenterology.

Electrochemotherapy for Colorectal Cancer with Commonly Used Chemotherapeutic Agents in a Mouse Model

S. Kuriyama, A. Mitoro, H. Tsujinoue, 2000, Digestive Diseases and Sciences.

Identification of p46 Shc expressed in the nuclei of hepatocytes with high proliferating activity: Study of regenerating rat liver.

H. Yoshiji, T. Masaki, S. Kuriyama, 2004, International journal of molecular medicine.

Stage I mantle-cell lymphoma that was difficult to differentiate from abdominal tuberculous lymphadenitis and metastatic pancreatic cancer

H. Yoshiji, S. Kuriyama, M. Tsutsumi, 2002, Journal of Gastroenterology.

Inhibitory effects of human sera on adenovirus-mediated gene transfer into rat liver.

S. Kuriyama, S. Nagao, A. Mitoro, 1998, Anticancer research.

Hepatic adenomas treated with percutaneous ethanol injection in a patient with glycogen storage disease type Ia

S. Kuriyama, T. Tsujimoto, M. Tsutsumi, 2001, Journal of Gastroenterology.

Blockade of renin–angiotensin system in antifibrotic therapy

H. Yoshiji, S. Kuriyama, H. Fukui, 2007, Journal of gastroenterology and hepatology.

Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, Gut.

Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development.

H. Yoshiji, T. Masaki, S. Kuriyama, 2004, Journal of hepatology.

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice

H. Yoshiji, D. Hicklin, T. Masaki, 2004, Hepatology.

Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.

H. Yoshiji, T. Masaki, S. Kuriyama, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Angiotensin-I-Converting Enzyme Inhibitors May Be an Alternative Anti-Angiogenic Strategy in the Treatment of Liver Fibrosis and Hepatocellular Carcinoma

H. Yoshiji, S. Kuriyama, H. Fukui, 2002, Tumor Biology.

5 Role of p107 expression in colorectal carcinoma

Fei Wu, T. Masaki, S. Kuriyama, 2002 .

Utility of pancreatic duct brushing for diagnosis of pancreatic carcinoma

R. Haba, T. Masaki, S. Kuriyama, 2007, Journal of Gastroenterology.

Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.

H. Yoshiji, T. Masaki, S. Kuriyama, 2007, International journal of oncology.

Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, International journal of oncology.

Percutaneous local therapies for hepatocellular carcinoma impair gastric function.

T. Masaki, S. Kuriyama, Hirohito Yoneyama, 2006, World journal of gastroenterology.

Amelioration of retrovirus-mediated gene transfer into hepatocellular carcinoma cells.

H. Yoshiji, S. Kuriyama, K. Ikenaka, 2001, International journal of oncology.

A CASE OF RECTAL ANGIODYSPLASIA THAT DISAPPEARED SPONTANEOUSLY AFTER MASSIVE BLEEDING

S. Kuriyama, M. Kikukawa, H. Tsujinoue, 2001 .

Immunomodulation with FK506 around the time of intravenous re‐administration of an adenoviral vector facilitates gene transfer into primed rat liver

S. Kuriyama, S. Nagao, A. Mitoro, 2000, International journal of cancer.

Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions

H. Maeta, T. Masaki, S. Kuriyama, 2003, Journal of surgical oncology.

Development of hepatocytes from embryonic stem cells after transfection with the HNF‐3β gene

S. Kuriyama, T. Hasuma, Seiji Kanda, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.

H. Yoshiji, S. Kuriyama, K. Ikenaka, 1999, International journal of cancer.

Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor.

H. Yoshiji, S. Kuriyama, H. Fukui, 2002, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Pre‐cutting using a noseless papillotome with independent lumens for contrast material and guidewire

T. Masaki, S. Kuriyama, Seishiro Watanabe, 2005, Journal of gastroenterology and hepatology.

Combination of copper-chelating agent, trientine, and methotrexate attenuates colorectal carcinoma development and angiogenesis in mice.

H. Yoshiji, S. Kuriyama, M. Yamazaki, 2005, Oncology Report.

The copper-chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppression.

H. Yoshiji, S. Kuriyama, H. Imazu, 2003, Oncology Report.

Cancer gene therapy with HSV‐tk/GCV system depends on t‐cell‐mediated immune responses and causes apoptotic death of tumor cells In vivo

H. Yoshiji, S. Kuriyama, K. Ikenaka, 1999 .

Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma.

S. Kuriyama, Jian-ying Zhang, E. Chan, 2005, International journal of oncology.

[A case of intrahepatic splenosis].

S. Kuriyama, T. Tsujimoto, H. Fukui, 2007, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

CYFRA 21-1 is released in TNF-alpha-induced apoptosis in the hepatocellular carcinoma cell line HuH-7.

Jia-qing Li, Fei Wu, J. Fujita, 2002, International journal of oncology.

Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.

T. Masaki, S. Kuriyama, Y. Shiratori, 2002, International journal of oncology.

Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats.

H. Yoshiji, T. Masaki, S. Kuriyama, 2004, International Journal of Molecular Medicine.

Multidisciplinary treatment of patients with hepatocellular carcinoma

T. Masaki, S. Kuriyama, A. Morishita, 2006, Expert review of anticancer therapy.

Enhancing effects of oral adjuvants on anti-HBs responses induced by hepatitis B vaccine.

S. Kuriyama, M. Matsumoto, S. Ishizaka, 1988, Clinical and experimental immunology.

Intravenous readministration of an adenoviral vector performed long after the initial administration failed to induce re-expression of the original transgene in rats.

H. Yoshiji, S. Kuriyama, K. Asada, 2001, International journal of oncology.

Intragastric administration of ursodeoxycholic acid suppresses immunoglobulin secretion by lymphocytes from liver, but not from peripheral blood, spleen or Peyer's patches in mice.

S. Kuriyama, H. Kawamoto, H. Fukui, 1998, International journal of immunopharmacology.

Tissue inhibitor of metalloproteinases‐1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse

H. Yoshiji, S. Kuriyama, H. Imazu, 2002, Hepatology.

Enhancing and suppressing effects of dexamethasone on transgene expression in vitro.

H. Yoshiji, H. Ohgushi, S. Kuriyama, 2002, International journal of molecular medicine.

Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma

S. Kuriyama, K. Ikenaka, T. Nakatani, 1995, Hepatology.

Thoracoscopic ethanol injection and radiofrequency ablation for the treatment of hepatocellular carcinoma located immediately under the diaphragm.

T. Masaki, S. Kuriyama, Hirohito Yoneyama, 2006, International journal of oncology.

A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma.

T. Masaki, S. Kuriyama, H. Miyoshi, 2008, World journal of gastroenterology.

Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targetting intervention radiology.

T. Masaki, S. Kuriyama, H. Miyoshi, 2007, World journal of gastroenterology.

Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.

T. Masaki, S. Kuriyama, A. Morishita, 2006, International journal of oncology.

Repetitive and safe transgene expression in rat liver is achievable by adenoviral infusion into the common bile duct.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, International Journal of Molecular Medicine.

Improved survival benefits with radiofrequency ablation for liver cancer.

S. Kuriyama, 2005, Cancer Treatment Reviews.

Safe and efficient transgene expression in rat hepatocytes induced by adenoviral administration into the biliary tract.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, Oncology Report.

Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma.

T. Masaki, S. Kuriyama, Hirohito Yoneyama, 2005, World journal of gastroenterology.

Efficacy of combination therapies of percutaneous or laparoscopic ethanol-lipiodol injection and radiofrequency ablation.

T. Masaki, S. Kuriyama, Hirohito Yoneyama, 2004, International Journal of Oncology.

Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.

T. Masaki, S. Kuriyama, Seishiro Watanabe, 2002, International journal of oncology.

Adenovirus-mediated gene transfer into tumors: evaluation of direct readministration of an adenoviral vector into subcutaneous tumors of immunocompetent mice.

H. Yoshiji, S. Kuriyama, S. Nagao, 2001, International journal of oncology.

Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation.

T. Masaki, S. Kuriyama, Hirohito Yoneyama, 2006, Oncology reports.

A CASE OF PEMPHIGUS VULGARIS INVOLVING THE EISOPHAGUS

S. Kuriyama, T. Muramatsu, M. Kikukawa, 2000 .

Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

H. Yoshiji, S. Kuriyama, H. Tsujinoue, 2001, Hepatology.

Perindopril: possible use in cancer therapy

H. Yoshiji, S. Kuriyama, H. Fukui, 2002 .

Perindopril: possible use in cancer therapy

H. Yoshiji, S. Kuriyama, H. Fukui, 2002 .

Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice.

H. Yoshiji, S. Kuriyama, R. Noguchi, 2005, Oncology reports.

Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.

Fei Wu, J. Fujita, S. Kuriyama, 2002, International journal of oncology.

pp60c-src activation in lung adenocarcinoma.

H. Yoshiji, S. Kuriyama, Hirohito Yoneyama, 2003, European journal of cancer.

In vivo gene transfer of a suicide gene under the transcriptional control of the carcinoembryonic antigen promoter results in bone marrow transduction but can avoid bone marrow suppression.

S. Kuriyama, Z. Qi, S. Nagao, 1999, International journal of oncology.